Rivaroxaban Versus Enoxaparin for Prophylaxis of Venous Thromboembolism in Bariatric Surgery
Recruiting · NCT06689241 · Interventional (participants receive a specific treatment) · Lead sponsor: Alexandria University
View the official record on ClinicalTrials.gov →Interventions studied
Enoxaparinrivaroxaban
What this trial is about
Rivaroxaban versus enoxaparin for prophylaxis of venous thromboembolism in morbidly obese patients undergoing bariatric surgery: An open\_label randomized controlled trial
Who can take part
Age range
20 Years to 60 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age: 20-60 years, both sexes.
- ASA physical status class I to III.
- BMI 35-50 kg/m²
Exclusion criteria
- Severe cardiac disorder
- chronic renal failure
- liver cirrhosis
- major psychological disorder
Where it is running
1 location listed.
- Alexandria University - Alexandria, Egypt